Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Heatwurx Inc. (PCSA) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Heatwurx Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Heatwurx Inc. and Reviva Pharmaceuticals Holdings, Inc. are of similar size ($5.2M and $5.0M). Reviva Pharmaceuticals Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Across the 7 metrics below, Heatwurx Inc. leads on 4 and Reviva Pharmaceuticals Holdings, Inc. on 3.

Valuation

Metric PCSA RVPH Biotechnology median
P/E 1.75 n/m 7.88
P/S 38.64 n/m 11.47
P/B n/m 0.42 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.84 0.74
EV/Sales 38.45 n/m 10.73
Earnings yield 57.14% (252.17%) (28.84%)
Free cash flow yield (259.68%) (272.92%) (23.03%)

Profitability

Metric PCSA RVPH Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (464.19%) (176.60%) (57.72%)
Return on assets (262.17%) (79.46%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PCSA RVPH Biotechnology median
Revenue growth (TTM) (34.50%) — 5.64%
EPS growth (last fiscal year) 89.29% 69.56% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PCSA RVPH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.87 3.56 4.73
Net debt to EBITDA 0.40 0.71 0.96

Dividend

Metric PCSA RVPH Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PCSA RVPH Biotechnology median
Market cap 5.17m 5.00m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack